Bionano Genomics Inc NASDAQ NMS - GLOBAL MARKET:BNGO
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-06-30 · prior 2025-03-31.
New Positions(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 8,582 | +8,582 | $2.5K | +$2.5K | — |
| Credential Qtrade Securities Inc. | 306 | +306 | $614 | +$614 | — |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| MORGAN STANLEY | 0 | -533,036 | $0 | -$153.7K | — |
| GROUP ONE TRADING, L.P. | 0 | -264,961 | $0 | -$76.4K | — |
| RAYMOND JAMES FINANCIAL INC | 0 | -19,750 | $0 | -$5.7K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-06-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 8,582 | $2.5K | +8,582 | — |
| Credential Qtrade Securities Inc. | 306 | $614 | +306 | — |
New & Closed Positions this quarter
- MORGAN STANLEY$153.7K
- GROUP ONE TRADING, L.P.$76.4K
- RAYMOND JAMES FINANCIAL INC$5.7K
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for BNGO against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.